Flumizole

Flumizole is a nonsteroidal anti-inflammatory drug (NSAID) that is used for its analgesic and anti-inflammatory properties. It is primarily used in the treatment of pain and inflammation associated with various conditions.
Pharmacology[edit]
Flumizole works by inhibiting the enzyme cyclooxygenase (COX), which is involved in the synthesis of prostaglandins. Prostaglandins are mediators of inflammation and pain. By inhibiting COX, flumizole reduces the production of prostaglandins, thereby alleviating pain and inflammation.
Indications[edit]
Flumizole is indicated for the treatment of:
- Rheumatoid arthritis
- Osteoarthritis
- Ankylosing spondylitis
- Acute pain conditions such as musculoskeletal pain and dental pain
Contraindications[edit]
Flumizole should not be used in patients with:
- Known hypersensitivity to flumizole or other NSAIDs
- History of gastrointestinal bleeding or peptic ulcer disease
- Severe renal impairment
- Severe hepatic impairment
- Asthma that is exacerbated by NSAIDs
Side Effects[edit]
Common side effects of flumizole include:
Serious side effects may include:
Dosage[edit]
The dosage of flumizole varies depending on the condition being treated and the patient's response to the medication. It is typically administered orally, and the dosage should be adjusted based on the severity of symptoms and patient tolerance.
Mechanism of Action[edit]
Flumizole inhibits both COX-1 and COX-2 enzymes, which are involved in the inflammatory process. COX-1 is responsible for the production of prostaglandins that protect the stomach lining and maintain kidney function, while COX-2 is primarily involved in the inflammatory response. By inhibiting these enzymes, flumizole reduces inflammation and pain.
Research[edit]
Ongoing research is being conducted to further understand the efficacy and safety profile of flumizole in various inflammatory conditions. Studies are also exploring its potential use in other therapeutic areas.
See Also[edit]
References[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian